Analysis of interference criteria for the validation of a method file : HPS staining after fixation with zinc-formalin in comparison to fixation with the classical 4% buffered formalin solution
Copyright © 2020 Elsevier Masson SAS. All rights reserved..
INTRODUCTION: The department of neuropathology of Sainte-Anne Hospital uses zinc-formalin as the fixative agent for its samples. No publication referenced in Pubmed has proven the validity of this fixative agent. In the context of the accreditation of our standard staining (HPS for Hemalun-Phloxin-Saffron), we started a file for the validation of this method in which the fixative agent constitutes an « interfering » substance which can modify the quality of the technique. The aim of this study was to prove that the use of zinc-formalin as a fixative agent is as suitable as the fixation with 4 % buffered formalin.
MATERIALS AND METHODS: A cohort of samples fixed by zinc-formalin and by 4 % buffered formalin was performed on fresh samples, then cut and stained by HPS. The slides were interpreted by three pathologists (one of them was outside our centre) ``blind '' to the fixative agent and they evaluated four criteria (general quality of the staining, components of the extracellular matrix, cytoplasmic details, and nuclear details) and scored them (from 0 to 3) according to the Association française en assurance qualité (AFAQAP) recommendations.
RESULTS: The cohort included 43 samples. The results of the analysis showed that for samples fixed by zinc-formalin, three of the four criteria obtained significantly a better score than the samples fixed by classical formalin.
DISCUSSION AND CONCLUSIONS: Our results show that the zinc-formalin fixative does not constitute an ``interfering '' agent for the quality of the HPS staining for neuropathological samples.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:41 |
|---|---|
| Enthalten in: |
Annales de pathologie - 41(2021), 3 vom: 08. Juni, Seite 310-316 |
| Sprache: |
Französisch |
|---|
| Weiterer Titel: |
Étude de l’item d’interférence dans un dossier de validation de méthode : cas de la coloration HPS après fixation en formol-zinc et comparaison à la fixation en formol tamponné à 4 |
|---|
| Beteiligte Personen: |
Tauziède-Espariat, Arnault [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
1HG84L3525 |
|---|
| Anmerkungen: |
Date Completed 15.10.2021 Date Revised 15.10.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.annpat.2020.10.003 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM320569853 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM320569853 | ||
| 003 | DE-627 | ||
| 005 | 20231225173849.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||fre c | ||
| 024 | 7 | |a 10.1016/j.annpat.2020.10.003 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1068.xml |
| 035 | |a (DE-627)NLM320569853 | ||
| 035 | |a (NLM)33494953 | ||
| 035 | |a (PII)S0242-6498(20)30257-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a fre | ||
| 100 | 1 | |a Tauziède-Espariat, Arnault |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Analysis of interference criteria for the validation of a method file |b HPS staining after fixation with zinc-formalin in comparison to fixation with the classical 4% buffered formalin solution |
| 246 | 3 | 3 | |a Étude de l’item d’interférence dans un dossier de validation de méthode : cas de la coloration HPS après fixation en formol-zinc et comparaison à la fixation en formol tamponné à 4 |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 15.10.2021 | ||
| 500 | |a Date Revised 15.10.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2020 Elsevier Masson SAS. All rights reserved. | ||
| 520 | |a INTRODUCTION: The department of neuropathology of Sainte-Anne Hospital uses zinc-formalin as the fixative agent for its samples. No publication referenced in Pubmed has proven the validity of this fixative agent. In the context of the accreditation of our standard staining (HPS for Hemalun-Phloxin-Saffron), we started a file for the validation of this method in which the fixative agent constitutes an « interfering » substance which can modify the quality of the technique. The aim of this study was to prove that the use of zinc-formalin as a fixative agent is as suitable as the fixation with 4 % buffered formalin | ||
| 520 | |a MATERIALS AND METHODS: A cohort of samples fixed by zinc-formalin and by 4 % buffered formalin was performed on fresh samples, then cut and stained by HPS. The slides were interpreted by three pathologists (one of them was outside our centre) ``blind '' to the fixative agent and they evaluated four criteria (general quality of the staining, components of the extracellular matrix, cytoplasmic details, and nuclear details) and scored them (from 0 to 3) according to the Association française en assurance qualité (AFAQAP) recommendations | ||
| 520 | |a RESULTS: The cohort included 43 samples. The results of the analysis showed that for samples fixed by zinc-formalin, three of the four criteria obtained significantly a better score than the samples fixed by classical formalin | ||
| 520 | |a DISCUSSION AND CONCLUSIONS: Our results show that the zinc-formalin fixative does not constitute an ``interfering '' agent for the quality of the HPS staining for neuropathological samples | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Formol-zinc | |
| 650 | 4 | |a Hemalun-Phloxin-Saffron | |
| 650 | 4 | |a Hémalun-Phloxine-Safran | |
| 650 | 4 | |a Validation de méthode | |
| 650 | 4 | |a Validation method | |
| 650 | 4 | |a Zinc-formalin | |
| 650 | 7 | |a Fixatives |2 NLM | |
| 650 | 7 | |a Formaldehyde |2 NLM | |
| 650 | 7 | |a 1HG84L3525 |2 NLM | |
| 650 | 7 | |a Zinc |2 NLM | |
| 650 | 7 | |a J41CSQ7QDS |2 NLM | |
| 700 | 1 | |a Côme, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Massé, Joëlle |e verfasserin |4 aut | |
| 700 | 1 | |a Zaomi, Myriam |e verfasserin |4 aut | |
| 700 | 1 | |a Collard, Aurélien |e verfasserin |4 aut | |
| 700 | 1 | |a Lacombe, Joëlle |e verfasserin |4 aut | |
| 700 | 1 | |a Oliveiro, Michelle |e verfasserin |4 aut | |
| 700 | 1 | |a Mehdi, Leïla |e verfasserin |4 aut | |
| 700 | 1 | |a Pucelle, Noémie |e verfasserin |4 aut | |
| 700 | 1 | |a Gigant, Priscille |e verfasserin |4 aut | |
| 700 | 1 | |a Berthaud, Charlotte |e verfasserin |4 aut | |
| 700 | 1 | |a Thuries, Valérie |e verfasserin |4 aut | |
| 700 | 1 | |a Roux, Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Cazals-Hatem, Dominique |e verfasserin |4 aut | |
| 700 | 1 | |a Gareton, Albane |e verfasserin |4 aut | |
| 700 | 1 | |a Pagès, Mélanie |e verfasserin |4 aut | |
| 700 | 1 | |a Chrétien, Fabrice |e verfasserin |4 aut | |
| 700 | 1 | |a Varlet, Pascale |e verfasserin |4 aut | |
| 700 | 1 | |a Lechapt-Zalcman, Emmanuèle |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Annales de pathologie |d 1993 |g 41(2021), 3 vom: 08. Juni, Seite 310-316 |w (DE-627)NLM012646385 |x 0242-6498 |7 nnns |
| 773 | 1 | 8 | |g volume:41 |g year:2021 |g number:3 |g day:08 |g month:06 |g pages:310-316 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.annpat.2020.10.003 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 41 |j 2021 |e 3 |b 08 |c 06 |h 310-316 | ||